Pituitary Surgery in Elderly Patients: Is It Safe Beyond 75 Years?
As the global population ages, more elderly patients require surgical interventions, including pituitary surgery. However, data on the safety and effectiveness of pituitary surgery in patients aged 75 and older remain limited. This article explores a recent study evaluating surgical outcomes in this age group,...
Closure Strategy in Endoscopic Pituitary Surgery: Experience from 3,015 Patients
Introduction The closure step in endoscopic pituitary surgery is crucial and requires an effective strategy to minimize postoperative complications. Numerous surgical techniques have been described, but no clear consensus has been established. Methods Between January 2006 and March 2022, 3,015...
Giant Pituitary Tumors: Surgical Outcomes and Management
Introduction Giant pituitary tumors (>40 mm) present a major therapeutic challenge due to the lack of established guidelines. This retrospective study analyzes a large cohort of patients managed by an expert multidisciplinary team, focusing on treatments and postoperative outcomes. Methods...
Pituitary Surgery for Cushing’s Disease: A Comprehensive Overview
Introduction Pituitary surgery is the standard treatment for Cushing’s disease, offering high success rates in well-defined cases. This article explores the surgical approach, challenges, and key considerations to optimize patient outcomes. Surgical Approach For patients with clearly visualized adenomas on pituitary MRI,...
Efficacy of Endoscopic Endonasal Transsphenoidal Surgery for Cushing’s Disease in 230 Patients with Positive and Negative MRI
Introduction Cushing’s disease is a rare endocrine disorder caused by an excess production of cortisol due to a pituitary adenoma. Endoscopic endonasal transsphenoidal surgery (EETS) is the gold standard for tumor removal, but its effectiveness varies depending on MRI findings....
Pituitary Surgery: An Alternative to Dopamine Agonists for the Treatment of Microprolactinomas
Introduction Microprolactinomas are typically treated with dopamine agonists. However, data on the outcomes of patients treated with surgery remain limited. This study presents a large series of patients who underwent pituitary surgery for microprolactinomas and evaluates the efficacy and safety...
Pituitary Surgery: An Alternative to Dopamine Agonists for the Treatment of Microprolactinomas
Introduction Microprolactinomas are typically treated with dopamine agonists. However, little information is available on the outcomes of patients treated with surgery. This study reports a large series of patients who underwent pituitary surgery for microprolactinoma and evaluates the effectiveness and...